Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Dsip for Sale > DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide
DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide buy - large image1
DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide buy - image1
DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide buy - image2
DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide buy - image3
DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide buy - image4
DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide buy - image5
DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide buy - image6

DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide

17 Inquiries

Unit Price:

$60/UNIT FOB

Get Latest Price
CAS No.:

62568-57-4

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Brand:

CQ

Packaging:

2mg*10vials,10vials/box

Price valid (until):

2027-08-29

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Tirzepatide,Retatrutide,Semaglutide,Cagrilintide,NAD+,copper peptide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

                                                                                                                           Sales manager: Coco
                                                                        whatsapp:+86 18333957523
                                                                        Email:coco@xtzhongsheng.com


       Product Detail   


    Items Specifications
    CAS  62568-57-4
    Purity >99%
    Type antioxidant and anti-anxiety effects.
    preserve condition −20°C

    Detailed Introduction to DSIP Products

    I. Basic Information

    DSIP, short for Delta Sleep-Inducing Peptide, is a naturally occurring neuropeptide first discovered in rabbit cerebrospinal fluid in 1974. Composed of 9 amino acids (sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) with a molecular weight of approximately 848.8 daltons, it exhibits various biological activities such as regulating sleep, calming the nerves, and maintaining physiological rhythms.

    As an endogenous peptide, DSIP does not directly induce sleep. Instead, it improves sleep quality, prolongs deep sleep cycles, and exerts indirect effects on the body’s stress response and emotional regulation by influencing the balance of neurotransmitters (e.g., gamma-aminobutyric acid, serotonin) in the central nervous system.

    II. Mechanism of Action

    The core mechanism of DSIP revolves around the regulation of the central nervous system, mainly including:

    1. Sleep regulation: By binding to receptors in sleep-related brain regions such as the hypothalamus and brainstem, it optimizes sleep structure, reduces sleep latency, increases the proportion of slow-wave (deep) sleep, and decreases the frequency of sleep interruptions.

    2. Sedation: It inhibits the overactivation of the hypothalamic-pituitary-adrenal (HPA) axis, reduces the secretion of stress hormones (e.g., cortisol), alleviates anxiety and tension, and produces a sedative effect without significant drowsiness.

    3. Neuroprotection: Studies suggest that DSIP may protect nerve cells by inhibiting oxidative stress and inflammatory responses, with potential protective effects against brain damage and cognitive decline.

    4. Endocrine regulation: It indirectly affects the secretion rhythms of hormones such as growth hormone and melatonin, participating in the maintenance of body metabolism and circadian rhythms.

    III. Research Data and Application Scenarios

    1. Preclinical studies:

    ◦ Animal experiments show that DSIP can significantly prolong deep sleep time in rats without disrupting normal sleep cycles (unlike sedatives, it does not cause next-day drowsiness or sleep structure damage).

    ◦ In stress models, DSIP reduces cortisol levels in rats, alleviates anxious behaviors, and improves stress-induced sleep disorders.

    2. Clinical research and potential applications:

    ◦ Sleep disorders: Small-scale studies on patients with insomnia and sleep apnea syndrome indicate that DSIP can improve sleep efficiency, reduce nighttime awakenings, and has high safety.

    ◦ Stress-related diseases: In conditions such as chronic fatigue syndrome and post-traumatic stress disorder (PTSD), DSIP may alleviate symptoms by regulating the HPA axis.

    IV. Product Parameters

    • English Name: Delta Sleep-Inducing Peptide (DSIP)

    • Amino Acid Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

    • Molecular Weight: 848.8 g/mol

    • CAS Number: 62568-67-4

    • Purity Specification: ≥98% (HPLC-tested)

    • Physical Form: White lyophilized powder, soluble in water or physiological saline

    • Storage Conditions: Store at -20°C in a sealed, light-protected container; avoid repeated freeze-thaw cycles

    V. Advantages and Precautions

    1. Core Advantages:

    ◦ As a natural endogenous peptide, it has high biocompatibility and few side effects (unlike benzodiazepine sedatives, it carries no risk of addiction or respiratory depression).

    ◦ It regulates sleep rhythms without directly inhibiting the central nervous system, making it more suitable for improving chronic sleep disorders.

    ◦ It has potential  neuroprotective properties, enabling a wide range of applications.

    2. Precautions:

    ◦ Currently, it is mainly in the research stage and not yet widely used clinically; use under professional guidance is required.

    ◦ Lyophilized powder must be stored strictly according to the specified conditions; reconstituted solutions should be used as soon as possible to avoid degradation.

    VI. Research Prospects

    Due to its unique sleep-regulating mechanism and favorable safety profile, DSIP has become a research hotspot in sleep medicine, neurodegenerative diseases, and stress-related fields. With the advancement of clinical trials, it is expected to be developed into a new peptide drug for treating chronic insomnia, anxiety, and neuroprotection, offering new options for improving body physiological rhythms and nerve function.

    Shop DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide-Detailed Image 1
    Shop DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide-Detailed Image 2
    Shop DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide-Detailed Image 3 Shop DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide-Detailed Image 4 Shop DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide-Detailed Image 5 Shop DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide-Detailed Image 6 Shop DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide-Detailed Image 7 Shop DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide-Detailed Image 8


       Company Profile  


     Our company is a modern advanced enterprise specializing in production and exportation of APIs, Pharmaceutical intermediates, plant extracts etc. Our products are widely used in medicine, health care products, cosmetics, nutritional supplements and food additives areas. Our factory covers an area of 95 acres, the proposed construction of the plant will be GMP standards, the factory environment clean and tidy, rational layout, with large and medium-sized production workshop and repocessed shop. It is equipped with advanced equipment quality inspection and research center. Those products of both quality and technical content have reached the domestic advanced level. Since its establishment, the company has attached great importance to the team training and technical reform. Our modern production equipment guarantees for a fast and effective production with a superior degree of accuracy throughout the whole production line, everything is done in-house, processing, extraction, packaging and transportation of all links, ensuring maximum quality and efficiency. We are constantly research and development new ingredients and innovative new products, have earned the respect & Admiration from the worldwide customers. After years of continuous development, company has been accumulated rich experience in international trade and customer resources, established a stable customer base and perfect marketing service network. In addition, the company has established long-term technical cooperation with experts and professors from many universities and research institutes in the province.

    Shop DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide-Detailed Image 9 Shop DSIP 2mg 5mg 15mg Delta-Sleep Inducing Peptide/Dsip CAS 62568-57-4 Emideltide-Detailed Image 10

    Basic Info
    Product Name:

    Dsip

    CAS No.:

    62568-57-4

    Molecular Formula:

    C35H48N10O15

    InChIKeys:

    ZRZROXNBKJAOKB-GFVHOAGBSA-N

    Molecular Weight:

    848.8

    Exact Mass:

    848.33006086

    UNII:

    YN28Z5YZ73

    Characteristics

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,Semaglutide,Cagrilintide,NAD+,copper peptide

    Location:

    room 102, No. 60-20, Gongnong Street, Xiangya Road Subdistrict, Kaifu District, Changsha City, Hunan Province, China

    Payment Terms:

    TT against copy of documents,D/P,L/C,TT against B/L draft before shipment

    Average lead Time:

    2

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2023

    Changsha Caoquan Technology Co., Ltd

    Changsha Caoquan Technology Co., Ltd was established in 2020 with strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures.

    With synthetic biology platform technology as the core, it conducts innovative research and development, mainly engaged in the research and development of recombinantly expressed pharmaceutical peptides and proteins. Its products include innovative drugs, APIs, pharmaceutical and green synthetic industrial enzymes, functional peptides and protein products, etc.

    Its core team is composed of technical experts in the fields of pharmaceutical engineering, fermentation engineering and protein engineering. The company has built a 3,300-square-meter recombinant drug research and development center in Shibei, Yuelu District, Changsha City. It has a complete pharmaceutical engineering, preparation and quality research system and talent team, and has built a GMP workshop to meet the international market API supply and CDMO services.

    At present, our company has realized the industrialization of a variety of biosynthetic peptide products and has obtained cooperation orders from many well-known domestic and foreign pharmaceutical companies.

  • Inquiry History
    17 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Dsip

    10 G Jan 12, 2026
    Germany

    Dsip

    1 MT Apr 26, 2026
    United States

    DSIP

    10 MT Mar 12, 2026
    United States

    DSIP

    10 MG Jan 12, 2026
    United States

    DSIP

    1 G Nov 10, 2025
    United States

    dsip

    Oct 20, 2025
    United States

    DSIP lyphilized powder

    100 MG Jun 24, 2025
    United States

    Adipotide 5mg 10vial kit

    1 MT Feb 25, 2024
    United States

    dsip

    100 G May 17, 2026
    United States

    DSIP

    10 MT Apr 27, 2026
    United States

    DSIP

    10  Apr 13, 2026
    United States

    DSIP

    1 MT Apr 10, 2026
    United States

    Dsip

    100 MT Feb 3, 2026
    United States

    Dsip

    1 MT Dec 17, 2025
    Italy

    Adipotide

    100 MG Jun 2, 2024
    United States

    DSIP

    100 MG Nov 28, 2025
    United States

    Epitalon, NAD+, DSIP, 5-Amino-1MQ, PEG-MGF

    May 9, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.